Next |
home / stock / hema / hema message board
Subject | By | Source | When |
---|---|---|---|
$HEMA: Acquired by Charles River Laboratories International, Inc. | Renee | investorshub | 01/03/2020 9:54:09 PM |
So, after all your questions that I told | dg33 | investorshub | 12/16/2019 9:30:06 PM |
whytestocks: $HEMA News Article - HEMACARE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of H | whytestocks | investorshangout | 12/16/2019 6:40:44 PM |
whytestocks: $HEMA News Article - Charles River Laboratories to Acquire HemaCare Corporation | whytestocks | investorshangout | 12/16/2019 2:05:43 PM |
Can you point to where it is false? | Steve07 | investorshub | 09/23/2019 8:30:57 PM |
As a health care provider and having worked | dg33 | investorshub | 09/23/2019 8:24:49 PM |
DG33 it appears that you don't have a | Steve07 | investorshub | 09/23/2019 7:02:24 PM |
> It appears that this Charles River announcement | dg33 | investorshub | 09/23/2019 4:46:39 PM |
While Allcells products are sold under the Lonza | Steve07 | investorshub | 09/23/2019 3:41:57 PM |
It's great that $HEMA was able to team | dg33 | investorshub | 09/23/2019 2:57:35 PM |
It appears that Lonza elected to team up | Steve07 | investorshub | 09/22/2019 1:22:37 PM |
Steve07 | investorshub | 09/22/2019 1:22:32 PM | |
Steve07 | investorshub | 09/22/2019 1:22:12 PM | |
Steve07 | investorshub | 09/22/2019 1:22:10 PM | |
It appears that Lonza elected to team up | Steve07 | investorshub | 09/22/2019 1:21:53 PM |
Here's what makes $HEMA special: | dg33 | investorshub | 09/21/2019 1:32:45 PM |
1. They do not have a massive number | dg33 | investorshub | 08/28/2019 2:35:53 AM |
whytestocks: $HEMA News Article - HemaCare and Charles River Laboratories Partner to Provide Human-D | whytestocks | investorshangout | 08/27/2019 4:20:40 PM |
If I am not mistaken, this is a | Steve07 | investorshub | 08/20/2019 6:25:45 PM |
China represents an additional 1.4 billion potential customers | dg33 | investorshub | 06/17/2019 4:29:02 AM |
News, Short Squeeze, Breakout and More Instantly...
– Expands Charles River’s Scientific Capabilities in the High-Growth Cell Therapy Market – – Establishes a Comprehensive Cell Therapy Solution from Discovery through Commercialization – Charles River Laboratories International, Inc. (NYSE: CR...
Advancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting material HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery,...
New distribution partnership allows high-quality human primary cells to reach the Chinese market HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and c...